Taking people in DenmarkPhase 1
Testing a radioactive uPAR-targeted drug dose in people with glioblastoma
Tests a radiation-carrying drug that targets uPAR in adults with glioblastoma.
Plain-language title generated from the registry record
Registry title: A dosimetry trial of uPAR targeted radioligand therapy in patients with glioblastoma
Key facts
- Where
- Copenhagen Oe, DenmarkSee the site
- Phase
- Phase 1
Where in Denmark
- RigshospitaletCopenhagen Oe, DenmarkTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Curasight A/S
- Trial code
- EU 2024-520105-39-00
- Record updated
- 30 September 2026